Fig. 3

A UBE2T expression was efficiently knocked down by siRNAs in SKOV3 and HO8910 cells. siRNA, small interfering RNA; UBE2T, ubiquitin-binding enzyme E2T. B UBE2T knockout significantly inhibited ovarian cancer cell proliferation (SKOV3). OD, optical density; si-NC, small interfering RNA-negative control; UBE2T, ubiquitin-binding enzyme E2T. C UBE2T knockout significantly inhibited ovarian cancer cell proliferation (HO8910). OD, optical density; si-NC, small interfering RNA-negative control; UBE2T, ubiquitin-binding enzyme E2T. D UBE2T knockout significantly inhibited the invasive ability of ovarian cancer cells. si-NC, small interfering RNA-negative control; UBE2T, ubiquitin-binding enzyme E2T. E UBE2T silencing significantly decreased the invasive ability of ovarian cancer cells. si-NC, small interfering RNA-negative control; UBE2T, ubiquitin-binding enzyme E2T